Bio-Path Holdings Inc (BPTH)
2.03
+0.02
(+1.00%)
USD |
NASDAQ |
May 24, 16:00
2.03
0.00 (0.00%)
After-Hours: 20:00
Bio-Path Holdings Enterprise Value: 3.174M for May 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 24, 2024 | 3.174M |
| May 23, 2024 | 3.141M |
| May 22, 2024 | 3.323M |
| May 21, 2024 | 3.124M |
| May 20, 2024 | 3.406M |
| May 17, 2024 | 3.356M |
| May 16, 2024 | 3.688M |
| May 15, 2024 | 3.522M |
| May 14, 2024 | 4.085M |
| May 13, 2024 | 4.052M |
| May 10, 2024 | 4.317M |
| May 09, 2024 | 4.466M |
| May 08, 2024 | 4.132M |
| May 07, 2024 | 4.508M |
| May 06, 2024 | 4.054M |
| May 03, 2024 | 3.897M |
| May 02, 2024 | 3.976M |
| May 01, 2024 | 4.132M |
| April 30, 2024 | 4.242M |
| April 29, 2024 | 4.273M |
| April 26, 2024 | 4.007M |
| April 25, 2024 | 3.937M |
| April 24, 2024 | 3.710M |
| April 23, 2024 | 4.015M |
| April 22, 2024 | 4.383M |
| Date | Value |
|---|---|
| April 19, 2024 | 6.527M |
| April 18, 2024 | 4.811M |
| April 17, 2024 | 2.254M |
| April 16, 2024 | 2.111M |
| April 15, 2024 | 2.028M |
| April 12, 2024 | 2.111M |
| April 11, 2024 | 2.186M |
| April 10, 2024 | 2.420M |
| April 09, 2024 | 2.692M |
| April 08, 2024 | 2.744M |
| April 05, 2024 | 2.986M |
| April 04, 2024 | 3.053M |
| April 03, 2024 | 3.055M |
| April 02, 2024 | 3.004M |
| April 01, 2024 | 3.280M |
| March 28, 2024 | 1.745M |
| March 27, 2024 | 1.690M |
| March 26, 2024 | 1.677M |
| March 25, 2024 | 1.514M |
| March 22, 2024 | 1.904M |
| March 21, 2024 | 1.853M |
| March 20, 2024 | 1.901M |
| March 19, 2024 | 2.043M |
| March 18, 2024 | 2.247M |
| March 15, 2024 | 2.070M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-9.092M
Minimum
Mar 16 2020
40.02M
Maximum
Feb 18 2021
7.198M
Average
4.765M
Median
Nov 06 2023
Enterprise Value Benchmarks
| INVO Bioscience Inc | 12.30M |
| Perspective Therapeutics Inc | 755.01M |
| EyePoint Pharmaceuticals Inc | 281.91M |
| Palatin Technologies Inc | 22.26M |
| Lumos Pharma Inc | -3.286M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.157M |
| Total Expenses (Quarterly) | 3.695M |
| EPS Diluted (Quarterly) | -4.88 |
| Earnings Yield | -1.29K% |
| Normalized Earnings Yield | -19717.16 |